6 results
IDSA Recommendations for empirical antimicrobial therapy for purulent meningitis based on patient age and specific predisposing
IDSA Recommendations ... condition #IDSA ... Antimicrobials #Empiric #Coverage ... InfectiousDiseases #Pharmacology ... #Management
IDSA 2017 CDiff Guidelines - Table 7. Potential Treatment Agents for Treatment of the Primary Clostridium difficile
IDSA 2017 CDiff ... infection Episode #Pharmacology ... #Management #CDiff
Antibiotics for Anaerobic Bacteria 
 - Metronidazole (Flagyl™) 
 - Carbapenems 
 - β lactam +
out of favor for C.diff ... Anaerobic #Bacteria #Pharmacology ... Susceptibility #Coverage ... #Management
Spectrum of activity for systemic antifungal agents
Antifungals: 5FC, flucytosine; AMB, amphotericin B; ANI, anidulafungin; CAS, caspofungin;
fluconazole; ISA ... #antibiogram #management ... #pharmacology # ... spectrum #coverage
For my UME micro course, I made a figure that captures this terminology and lets learners
‘broaden’ this coverage ... I’ve drawn the broad ... holes” in their coverage ... #antibiogram #pharmacology ... #management #spectrum
Potential Treatment Agents for Treatment of the Primary Clostridium difficile infection Episode
Proven efficacy:
 • Vancomycin -
× 10 days #CDiff ... options #treatment #management ... #pharmacology # ... idsa #table